The historical rank and industry rank for Syngene International's OCF Margin % or its related term are showing as below:
BOM:539268'
s OCF Margin % Range Over the Past 10 Years
Min: 23.16 Med: 32.81 Max: 36.75
Current: 24.48
During the past 13 years, the highest OCF Margin % of Syngene International was 36.75%. The lowest was 23.16%. And the median was 32.81%.
BOM:539268's OCF Margin % is ranked better than 84.31% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs BOM:539268: 24.48
Syngene International OCF Margin % Related Terms
Syngene International OCF Margin % Historical Data
* Premium members only.
The historical data trend for Syngene International's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539268 vs TMO, DHR, IDXX: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Syngene International's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syngene International OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Syngene International's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Syngene International's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syngene International (BOM:539268) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Syngene International and its competitors. Over the past decade, Syngene International's OCF Margin % has ranged from 23.16 to 36.75. According to the industry distribution chart, Syngene International ranks #32 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 15.7%.
Is Syngene International's OCF Margin % too high?
Syngene International's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 23.16 to a high of 36.75. Based on the distribution chart, Syngene International ranks #32 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Syngene International has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Syngene International ranks #32 out of 204 companies for OCF Margin %. This places Syngene International in the top 16% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.76. Historically, Syngene International's own OCF Margin % has ranged from 23.16 to 36.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Syngene International and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syngene International's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (BOM:539268) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹788.42, compared to a current price of ₹442.95 — trading 43.8% below its estimated fair value. The current OCF Margin % is 0.00%. Syngene International's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Syngene International (BOM:539268), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syngene International (BOM:539268) Overvalued in 2026?
Based on GuruFocus' analysis, Syngene International stock appears to be undervalued.
The current stock price of ₹442.95 is trading 43.8% below its estimated GF Value™ of ₹788.42.
GuruFocus considers Syngene International to be Significantly Undervalued.
Key valuation signals for BOM:539268:
OCF Margin %: 0.00%
GF Value™: ₹788.42 vs. price of ₹442.95 (43.8% below fair value)
No single metric tells the full story. See the BOM:539268 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
81GF Score
Get the complete analysis for BOM:539268
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539268 has been successfully added to your 
